Copyright
©The Author(s) 2024.
World J Radiol. May 28, 2024; 16(5): 128-135
Published online May 28, 2024. doi: 10.4329/wjr.v16.i5.128
Published online May 28, 2024. doi: 10.4329/wjr.v16.i5.128
Table 3 Use of magnetic resonance imaging contrast agents, n (%)
| MRI contrast agent | Number of patients |
| Meglumine gadoterate | 158 (56.2) |
| Gadoxetic acid disodium | 123 (43.8) |
| Total | 281 (100) |
- Citation: Aydin S, Aydin OC, Yazar MF, Aydemir H, Kantarci M, Barun S. Assessment of the potential interactions between favipiravir and radiocontrast agents. World J Radiol 2024; 16(5): 128-135
- URL: https://www.wjgnet.com/1949-8470/full/v16/i5/128.htm
- DOI: https://dx.doi.org/10.4329/wjr.v16.i5.128